Strength
5 mg/1
Manufacturer
E.R. Squibb & Sons, L.L.C.NDC
00003089470
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
1/1/2026
Active Ingredients
APIXABANApproval Type
New Drug (NDA)
FDA Application
NDA202155On Market Since
12/28/2012
Pharmacological Classes
Factor Xa Inhibitor
Factor Xa Inhibitors
Related Drugs
Same classification
XARELTO 1 MG/ML SUSPENSION
Brand
50458057501•Janssen Pharmaceuticals Inc.
$3.7634
per ML
XARELTO 2.5 MG TABLET
Brand
50458057710•Janssen Pharmaceuticals Inc.
$9.7866
per EA
XARELTO 2.5 MG TABLET
Brand
50458057718•Janssen Pharmaceuticals Inc.
$9.7866
per EA
XARELTO 2.5 MG TABLET
Brand
50458057760•Janssen Pharmaceuticals Inc.
$9.7866
per EA
SAVAYSA 60 MG TABLET
Brand
65597020305•Daiichi Sankyo Inc.
$12.4609
per EA
SAVAYSA 60 MG TABLET
Brand
65597020390•Daiichi Sankyo Inc.
$12.4609
per EA
SAVAYSA 30 MG TABLET
Brand
65597020205•Daiichi Sankyo Inc.
$12.4819
per EA
SAVAYSA 30 MG TABLET
Brand
65597020290•Daiichi Sankyo Inc.
$12.4819
per EA
SAVAYSA 30 MG TABLET
Brand
65597020230•Daiichi Sankyo Inc.
$14.5678
per EA
SAVAYSA 60 MG TABLET
Brand
65597020330•Daiichi Sankyo Inc.
$14.6324
per EA